Efficacy comparison of duloxetine and SSRIs at doses approved in Japan

Efficacy comparison of duloxetine and SSRIs at doses approved in Japan

Eiji Harada,1 Alexander Schacht,2 Tsukasa Koyama,3 Lauren Marangell,4,5 Toshinaga Tsuji,6 Rodrigo Escobar41Medical Science, Eli Lilly Japan K.K, Kobe, Japan; 2Global Statistical Sciences, Eli Lilly and Company, Bad Homburg, Germany; 3Clinical Research Center, Ohyachi Hospital, Sapporo, Japan; 4Eli...

Full description

Bibliographic Details
Main Authors: Harada E, Schacht A, Koyama T, Marangell LB, Tsuji T, Escobar R
Format: Article
Language:English
Published: Dove Medical Press 2015-01-01
Series:Neuropsychiatric Disease and Treatment
Online Access:http://www.dovepress.com/efficacy-comparison-of-duloxetine-and-ssris-atnbspdoses-approved-in-ja-peer-reviewed-article-NDT

Internet

http://www.dovepress.com/efficacy-comparison-of-duloxetine-and-ssris-atnbspdoses-approved-in-ja-peer-reviewed-article-NDT

Similar Items